Your browser doesn't support javascript.
loading
The sequences of 150,119 genomes in the UK Biobank.
Halldorsson, Bjarni V; Eggertsson, Hannes P; Moore, Kristjan H S; Hauswedell, Hannes; Eiriksson, Ogmundur; Ulfarsson, Magnus O; Palsson, Gunnar; Hardarson, Marteinn T; Oddsson, Asmundur; Jensson, Brynjar O; Kristmundsdottir, Snaedis; Sigurpalsdottir, Brynja D; Stefansson, Olafur A; Beyter, Doruk; Holley, Guillaume; Tragante, Vinicius; Gylfason, Arnaldur; Olason, Pall I; Zink, Florian; Asgeirsdottir, Margret; Sverrisson, Sverrir T; Sigurdsson, Brynjar; Gudjonsson, Sigurjon A; Sigurdsson, Gunnar T; Halldorsson, Gisli H; Sveinbjornsson, Gardar; Norland, Kristjan; Styrkarsdottir, Unnur; Magnusdottir, Droplaug N; Snorradottir, Steinunn; Kristinsson, Kari; Sobech, Emilia; Jonsson, Helgi; Geirsson, Arni J; Olafsson, Isleifur; Jonsson, Palmi; Pedersen, Ole Birger; Erikstrup, Christian; Brunak, Søren; Ostrowski, Sisse Rye; Thorleifsson, Gudmar; Jonsson, Frosti; Melsted, Pall; Jonsdottir, Ingileif; Rafnar, Thorunn; Holm, Hilma; Stefansson, Hreinn; Saemundsdottir, Jona; Gudbjartsson, Daniel F; Magnusson, Olafur T.
Afiliação
  • Halldorsson BV; deCODE genetics/Amgen Inc., Reykjavik, Iceland. bjarnih@decode.is.
  • Eggertsson HP; School of Technology, Reykjavik University, Reykjavik, Iceland. bjarnih@decode.is.
  • Moore KHS; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Hauswedell H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Eiriksson O; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Ulfarsson MO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Palsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Hardarson MT; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
  • Oddsson A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jensson BO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Kristmundsdottir S; School of Technology, Reykjavik University, Reykjavik, Iceland.
  • Sigurpalsdottir BD; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Stefansson OA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Beyter D; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Holley G; School of Technology, Reykjavik University, Reykjavik, Iceland.
  • Tragante V; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gylfason A; School of Technology, Reykjavik University, Reykjavik, Iceland.
  • Olason PI; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Zink F; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Asgeirsdottir M; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sverrisson ST; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sigurdsson B; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gudjonsson SA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sigurdsson GT; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sveinbjornsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Norland K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Styrkarsdottir U; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Magnusdottir DN; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Snorradottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Kristinsson K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sobech E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsson H; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Geirsson AJ; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Olafsson I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsson P; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Pedersen OB; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Erikstrup C; Landspitali-University Hospital, Reykjavik, Iceland.
  • Brunak S; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Ostrowski SR; Landspitali-University Hospital, Reykjavik, Iceland.
  • Thorleifsson G; Landspitali-University Hospital, Reykjavik, Iceland.
  • Jonsson F; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Melsted P; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Jonsdottir I; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Rafnar T; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Holm H; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Stefansson H; Department of Clinical Immunology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
  • Saemundsdottir J; Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark.
  • Magnusson OT; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Nature ; 607(7920): 732-740, 2022 07.
Article em En | MEDLINE | ID: mdl-35859178
ABSTRACT
Detailed knowledge of how diversity in the sequence of the human genome affects phenotypic diversity depends on a comprehensive and reliable characterization of both sequences and phenotypic variation. Over the past decade, insights into this relationship have been obtained from whole-exome sequencing or whole-genome sequencing of large cohorts with rich phenotypic data1,2. Here we describe the analysis of whole-genome sequencing of 150,119 individuals from the UK Biobank3. This constitutes a set of high-quality variants, including 585,040,410 single-nucleotide polymorphisms, representing 7.0% of all possible human single-nucleotide polymorphisms, and 58,707,036 indels. This large set of variants allows us to characterize selection based on sequence variation within a population through a depletion rank score of windows along the genome. Depletion rank analysis shows that coding exons represent a small fraction of regions in the genome subject to strong sequence conservation. We define three cohorts within the UK Biobank a large British Irish cohort, a smaller African cohort and a South Asian cohort. A haplotype reference panel is provided that allows reliable imputation of most variants carried by three or more sequenced individuals. We identified 895,055 structural variants and 2,536,688 microsatellites, groups of variants typically excluded from large-scale whole-genome sequencing studies. Using this formidable new resource, we provide several examples of trait associations for rare variants with large effects not found previously through studies based on whole-exome sequencing and/or imputation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genoma Humano / Bancos de Espécimes Biológicos / Genômica / Bases de Dados Genéticas / Sequenciamento Completo do Genoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / Asia / Europa Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Islândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genoma Humano / Bancos de Espécimes Biológicos / Genômica / Bases de Dados Genéticas / Sequenciamento Completo do Genoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / Asia / Europa Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Islândia